Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Capricor Therapeutics (CAPR) Return on Capital Employed (2016 - 2025)

Capricor Therapeutics (CAPR) has 15 years of Return on Capital Employed data on record, last reported at 0.85% in Q3 2025.

  • For Q3 2025, Return on Capital Employed fell 5.0% year-over-year to 0.85%; the TTM value through Sep 2025 reached 0.85%, down 5.0%, while the annual FY2024 figure was 0.45%, 59.0% up from the prior year.
  • Return on Capital Employed reached 0.85% in Q3 2025 per CAPR's latest filing, down from 0.64% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.38% in Q4 2024 and bottomed at 3.57% in Q3 2023.
  • Average Return on Capital Employed over 5 years is 1.03%, with a median of 0.8% recorded in 2024.
  • Peak YoY movement for Return on Capital Employed: crashed -271bps in 2023, then surged 277bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.55% in 2021, then tumbled by -90bps to 1.04% in 2022, then tumbled by -38bps to 1.44% in 2023, then soared by 73bps to 0.38% in 2024, then plummeted by -121bps to 0.85% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.85% in Q3 2025, 0.64% in Q2 2025, and 0.41% in Q1 2025.